Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers

Prostate cancer is the second leading cause of noncutaneous cancer-related deaths in American men. Androgen deprivation therapy (ADT), radical prostatectomy, and radiotherapy remain the primary treatment for patients with early-stage prostate cancer (castration-sensitive prostate cancer). Following...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra Ghosh, Taraswi, Mazumder, Suman, Davis, Joshua, Yadav, Jyoti, Akinpelu, Ayuba, Alnaim, Ahmed, Kumar, Harish, Waliagha, Razan, Church Bird, Allison E., Rais-Bahrami, Soroush, Bird, R. Curtis, Mistriotis, Panagiotis, Mishra, Amarjit, Yates, Clayton C., Mitra, Amit K., Arnold, Robert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355222/
https://www.ncbi.nlm.nih.gov/pubmed/37476073
http://dx.doi.org/10.1158/2767-9764.CRC-22-0427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355222/
https://www.ncbi.nlm.nih.gov/pubmed/37476073
http://dx.doi.org/10.1158/2767-9764.CRC-22-0427

Ejemplares similares